This protocol is judged by an institutional review board, an impartial team that evaluations any medical trials involving humans. If a review will involve a Program I drug, as soon as the board approves the protocol as moral, the scientists really have to submit an application for an investigational new drug (IND) number from the FDA.Some scientist